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Upon colonization of the intestinal epithelium, the attaching and effacing (AE) pathogen
Enterohemorrhagic Escherichia coli (EHEC) effaces microvilli and forms pedestal-like
structures beneath the adherent bacterium. The production of one of its virulence
factors, the phage-encoded Shiga toxin (Stx) results in systemic disease, including the
development of renal failure. Although EHEC does not productively infect conventional
mice, EHEC infection can be modeled in mice utilizing a derivative of the natural
murine AE pathogen Citrobacter rodentium (CR). Gavage of mice with CR(8Stx2dact), a
C. rodentium lysogenized by a phage encoding an Stx variant with high potency in mice,
features AE lesion formation on intestinal epithelium and Stx-mediated systemic disease,
including renal damage. This model is somewhat limited by mouse-to-mouse variation
in the course of disease, with the time to severe morbidity (and required euthanasia)
varying by as many as 5 days, a feature that limits pathological analysis at defined
stages of disease. In the current study, we altered and optimized the preparation, dose,
and mode of delivery of CR(8Stx2dact), using food-borne route of infection to generate
highly synchronous disease model. We found that food-borne inoculation of as few as
3 × 104 CR(8Stx2dact) resulted in productive colonization and severe systemic disease.
Upon inoculation of 1 × 108 bacteria, the majority of infected animals suffered weight
loss beginning 5 days post-infection and all required euthanasia on day 6 or 7. This
enhanced murine model for EHEC infection should facilitate characterization of the
pathology associated with specific phases of Stx-mediated disease.
Keywords:Citrobacter rodentium, shiga toxin, hemolytic uremic syndrome, enterohemorrhagic E. coli, food-borne
inoculation
INTRODUCTION
Enterohemorrhagic E. coli (EHEC) O157:H7 is a Gram-negative bacterium and a causative agent
of intestinal and systemic disease (Wadolkowski et al., 1990a; Robinson et al., 2006; Mohawk
and O’Brien, 2011; Melton-Celsa et al., 2012; Kaper and O’Brien, 2014). Humans are infected
by this organism through contaminated food or water. EHEC is a member of the family of
pathogenic bacteria known as attaching and effacing pathogens (AE pathogens), which include
enteropathogenic E. coli (EPEC) and Citrobacter rodentium (CR). These organisms are capable of
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triggering localized actin assembly on epithelial cells beneath
bound bacteria, forming pedestal-like structures (Brady et al.,
2007; Vingadassalom et al., 2009; Lai et al., 2013). EHEC,
however, is unique because it produces a potent phage-encoded
cytotoxin termed Shiga-toxin (Stx) that is the major agent that
causes the tissue damage during EHEC infection (Wadolkowski
et al., 1990a,b; Proulx et al., 2001; Thorpe et al., 2001; Robinson
et al., 2006; Obrig, 2010; Melton-Celsa et al., 2012). Upon
establishment of intestinal colonization, Stx promotes intestinal
damage resulting in bloody diarrhea. The toxin subsequently
translocates across the colonic epithelium into the bloodstream,
where it targets distal tissues, including the microvasculature
of the kidney, which expresses high levels of the Stx receptor,
globotriaosylceramide (Gb3) (Obrig et al., 1993; Obata et al.,
2008; Obrig, 2010; Melton-Celsa et al., 2012; Bunger et al.,
2013). Hence, EHEC infection exhibits distinct clinical phases
such as non-bloody diarrhea, followed by bloody diarrhea,
and systemic disease, the latter manifested most commonly
by hemolytic uremic syndrome (HUS), the triad of hemolytic
anemia, thromobocytopenia and renal failure (Keepers et al.,
2006; Obrig, 2010; Melton-Celsa et al., 2012; Davis et al., 2014;
Melton-Celsa and O’Brien, 2014; Freedman et al., 2016).
Mice are highly sensitive to Stx, which can cause renal tubular
damage following IP injection (Keepers et al., 2006; Mohawk
and O’Brien, 2011; Mallick et al., 2012). However, EHEC does
not efficiently infect conventional mice. Furthermore, although
germ-free and antibiotic-treated mice exhibit susceptibility to
EHEC infection, these models are not useful for studying
EHEC pathogenesis factors, as strains that lack colonization
factors required for AE lesion formation are not required for
virulence in these models (Wadolkowski et al., 1990a; Eaton
et al., 2008; Kamada et al., 2012). To address these limitations,
an alternative model, using conventional mice, was developed.
The native murine AE pathogen C. rodentium (CR), which like
EHEC forms attaching and effacing lesions, was lysogenized with
phage 81720a-02, isolated from an Stx-producing E. coli strain
(Mallick et al., 2012, 2014). This phage encodes and produces
Stx variant Stx2dact, which is activated ∼18-fold by intestinal
mucus (Mallick et al., 2012; Bunger et al., 2013), resulting in
high potency in mice (Teel et al., 2002; Bunger et al., 2013).
The oral gavage of mice with a high (5 × 109 CFU) dose of
an overnight culture of CR(81720a-02), herein referred to as
“CR(8Stx2dact)” for simplicity, recapitulates many of the features
of human EHEC infection in an Stx2dact-dependent manner,
including colitis, renal damage, weight loss, and systemic injury.
Notably, a major limitation of this model is that disease
kinetics are highly variable, with the duration of infection before
mice require euthanasia varying from 4 to 9 days (Mallick et al.,
2012). Thus, the unpredictable evolution of disease in this model
precludes a careful characterization of pathology associated with
distinct phases of infection (e.g., intestinal colonization, toxin
dissemination, and renal failure). In the current study, we
describe a method of preparation and delivery of the inoculum
that results in a highly synchronous disease course, which
should facilitate investigation of successive stages of Stx-mediated
disease, and may more closely model the course of oral infection
by an AE pathogen.
MATERIALS AND METHODS
Strains and Inoculum Preparation
Two days prior to infection, CR(8Stx2dact) and
CR(8Stx2dact::kan
R), described previously (Mallick et al.,
2012, 2014), were streaked from frozen glycerol stock
onto LB agar containing the appropriate antibiotic (i.e.,
10µg/ml chloramphenicol for CR(8Stx2dact), and 10µg/ml
chloramphenicol and 25µg/ml kanamycin CR(8Stx2dact::kan
R)
for single colonies. The following day, a single colony was
inoculated into 40ml LB broth (without antibiotic) in a 50ml
conical tube (VWR, catalog number 89039-662) and incubated at
37◦C with 5% CO2, without shaking but with the cap loosened to
allow for gas exchange. Cultures were incubated typically for 10–
12 h, to achieve an OD600 ∼ 0.6–0.7. The culture was centrifuged
at 10294× g for 12 min at room temperature. The bacterial pellet
was resuspended in 500µl of Dulbecco’s Phosphate-buffered
saline DPBS (Life technologies, catalog number 14190-144) and
then centrifuged at room temperature at 5226 × g for 2min.
Bacterial pellets were resuspended in 60µl of DPBS. Six micro
liter of a resuspended inoculum, encompassing ∼ 1 × 108
colony-forming units (cfu), was carefully pipetted onto a∼35mg
piece of Teklad 2918 irradiated rodent chow, visually ensuring
that the inoculum was fully absorbed into the food (∼1 min).
For smaller inoculums, overnight cultures were appropriately
diluted in PBS and into the food as described above. To titer
the dose, a sample of the rodent chow inoculated in parallel
was resuspended in 1 ml of DPBS, vortexed to disperse chow
and bacteria, serially diluted, and plated on LB agar containing
the appropriate antibiotic (i.e., 10µg/ml chloramphenicol for
CR(8Stx2dact), and 10µg/ml chloramphenicol and 25µg/ml
kanamycin CR(8Stx2dact::kan
R).
Infection of Mice
All procedures involving live animals were pre-approved by
Tufts University Institutional Animal Care and Use Committee
(IACUC). Five to six week old C57BL/6 mice were purchased
from Jackson Laboratory and housed for 1–2 weeks in the animal
facility at Tufts University School of Medicine prior to the start
of infection. One day prior to infection, mice were weighed,
cohoused on raised wire flooring to prevent coprophagy (Thoren
caging systems: CC90F01), and food-restricted for 12 h. After
food restriction, each mouse was individually placed into an
empty cage and presented with a ∼35mg piece of inoculated
rodent chow. After each mouse consumed the entire food
inoculum, mice were weighed and returned to the original cage
(without raised wire flooring) with access to unlimited food
and water. For dose-response studies, mice were returned to
caging with raised wire flooring to prevent coprophagy for the
duration of the infection. Infection was followed by monitoring
of CR(8Stx2dact) or CR(8Stx2dact::kan
R) titers in the feces, as
follows. Fecal samples, were weighed, suspended in DPBS at a
volume of 10µl per 1mg of stool, and suspensions were serially
diluted and plated on agar containing the appropriate antibiotic
(10µg/ml chloramphenicol for CR(8Stx2dact), and 10µg/ml
chloramphenicol and 25µg/ml kanamycin CR(8Stx2dact::kan
R).
Mice were weighed and observed for clinical distress (ruﬄed
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fur, paucity of movement, and shivering) each day. Mice with
greater than 12% body weight loss with or without signs of
distress, or 10% body weight loss with signs of distress, were
euthanized by CO2 inhalation followed by cervical dislocation. In
addition, in some experiments, colonic and luminal colonization
was measured by sacrificing mice at day 3, 4, or 5 post-infection.
Each colon was dissected and stool contents were removed by
gently pushing the stool through the colon with the smooth
edge of a scalpel. The colonic luminal contents were collected
by gently flushing the colons with 1ml of DPBS. Colonic
tissues were homogenized in 500µl of DPBS using a Fisher
Scientific PowerGen 125 Homogenizer. To determine the titer
of CR(8Stx2dact), colonic homogenates and luminal wash were
serially diluted and plated on LB agar containing the appropriate
antibiotic, as described above. For each weight loss experiment,
the data passed the KS normality test.
RESULTS
Inoculation of Mice by Feeding
CR(8Stx2dact) results in Efficient
Colonization
The growth conditions of the inoculum are likely to influence
the course of infection and disease. For example, host-adapted
C. rodentium present in the feces of infected mice are in a
hyper-infectious state, i.e., highly transmissible and capable of
accelerated colonic colonization, compared to C. rodentium
grown in LB (Wiles et al., 2005). EHEC grown in gnotobiotic
piglets also exhibit enhanced virulence-related phenotypes
(Brady et al., 2011). Thus, in considering ways to develop a
consistent and predictable CR(8Stx2dact) infection model, we
first revisited the preparation of the inoculum. The previous
described CR(8Stx2dact) infection model, utilized bacteria that
had been grown overnight to stationary phase (Mallick et al.,
2012), a growth phase associated with global physiologic changes
(Battesti et al., 2011), some of which alter infectivity and/or
virulence (Molofsky and Swanson, 2004; Sonenshein, 2005). In
addition, the CR(8Stx2dact) cultures had previously been shaken,
which facilitates aerobic growth and is predicted to sensitize
C. rodentium to acid killing (Smith and Bhagwat, 2013). Hence,
in our current study, we grew CR(8Stx2dact) in a 5% CO2
atmosphere without shaking, a condition predicted to temper
aerobic growth. These cultures were grown to an OD600 =
∼0.6–0.7.
In the previously described CR(8Stx2dact) model (Mallick
et al., 2012), bacteria were delivered to the intestinal tract
by oral gavage, a method that not only risks aspiration and
esophageal and/or gastric puncture, but also induces a host stress
response that might alter the course of infection (Hoggatt et al.,
2010; Walker et al., 2012). Methods for intestinal delivery of
pharmacological agents by feeding have been established that
minimize this stress response (Walker et al., 2012). Further,
delivery of Listeria monocytogenes in food rather than by gavage
altered the fate of bacteria in the host and the virulence factors
required for infection. (Bou Ghanem et al., 2012). Hence, 6–8
week old C57BL/6J mice were inoculated by ingestion of 1× 108
CFU of CR(8Stx2dact) absorbed into a small (∼35mg) piece of
rodent chow (Figure 1 and Materials and Methods).
To determine if inoculation of mice with CR(8Stx2dact) in this
manner resulted in efficient intestinal colonization, we used fecal
shedding CR(8Stx2dact) as a non-terminal indicator of colonic
colonization: on successive days following infection, we plated
for viable CR(8Stx2dact) on selective media. High levels of fecal
shedding, i.e., ∼107 cfu/g of feces, were observed on day 3 post-
infection, increasing to >108 cfu/g of feces on days 4 and 5
post-infection (Figure 2A). High levels of colonization were also
observed in colonic luminal washes and colonic homogenates
following sacrifice. These titers of CR(8Stx2dact) were roughly
equal to the peak fecal shedding, colonic colonization, and
luminal washes previously reported (Mallick et al., 2012, 2014)
by intra-gastric inoculation. These data indicate that ingestion
of food inoculated with mid-log phase bacteria grown without
shaking results in efficient intestinal colonization.
The production of Stx by C. rodentium has been associated
with slightly higher levels of intestinal colonization following
inoculation by oral gavage (Mallick et al., 2012, 2014).
Therefore, we also infected mice with CR(8Stx2dact::kan
R),
a CR(8Stx2dact) mutant that does not produce Stx. Fecal
shedding of CR(8Stx2dact::kan
R) was indistinguishable from that
of CR(8Stx2dact) (Figure 2A), and CR(8Stx2dact::kan
R) titers
were similar to those of CR(8Stx2dact) in luminal washes and
colonic homogenates. Thus, at least for this small sample size (n
= 5), Stx did not detectably promote colonization in this model
(Figure 2).
Food-Inoculation of Mice with As Few As
3 × 104 CR(8Stx2dact) results in
colonization, Disease, and Mortality
Mice are typically gavaged with 108 C. rodentium to initiate
productive infection. To determine if inoculation of C57/BL6J
mice with lower doses of CR(8Stx2dact) by our feeding model
would result in productive infection and disease, we fed groups
of 10 mice doses of CR(8Stx2dact) spanning four orders of
magnitude, from 3.5 × 108 down to 3 × 104. To avoid
coprophagy, which due to the ingestion of bacteria shed in feces
would confound accurate quantitation of the oral dose, the mice
were housed on elevated wire floors for the duration of the
infection. Fecal shedding of CR(8Stx2dact) revealed that although
the kinetics of intestinal colonization appeared to be slightly
delayed in mice receiving the lowest dose, all groups of mice
were colonized by day 5 post-infection and reached>108/g stool
by day 7 (Figure 3A). Similarly, all groups of mice lost weight,
the kinetics of which varied with dose: the first indication of
significant weight loss occurred on post-infection day 7 for the
group of mice infected with 7.5× 107 or 3.5× 108 CR(8Stx2dact),
day 8 for the group infected with 3.6 × 106, and day 9 for the
group infected with 3.0 × 104 (Figure 3B). Finally, all groups
of mice became moribund and required euthanasia (Figure 3C).
Consistent with the trends observed for the kinetics of intestinal
colonization and weight loss, mice infected with lower doses
exhibited a somewhat longer interval between inoculation and
required euthanasia: by day 7 post-infection, the group of mice
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FIGURE 1 | Schematic of food-borne inoculation of mice.
infected with 3.5 × 108 CR(8Stx2dact) were all euthanized,
whereas for groups of mice infected with 7.5 × 107, 3.6 × 105,
and 3.0 × 104 bacteria, the day at which 100% were euthanized
was day 8, 9, and 10, respectively. We conclude that feeding of
C57/BL6J mice with as few as 3.0 × 104 CR(8Stx2dact) results in
productive and lethal infection.
Mice Inoculated with CR(8Stx2dact) by
Feeding Suffer Synchronous Disease and
Mortality
Previous work revealed that the kinetics of disease following
gavage inoculation with stationary phase CR(8Stx2dact) varied
widely, e.g., resulting in required euthanasia as early as 4 days and
as late as 9 days post-infection within a given experiment (Mallick
et al., 2012). In contrast, the trend of delayed colonization
and disease kinetics observed for mice given different doses
of CR(8Stx2dact) by feeding suggested that the time course of
disease in this model may be more consistent than by oral
gavage. To carefully assess the time course of disease, in multiple
experiments mice were weighed daily after inoculation with
mouse chow containing the relatively high dose of 1 × 108
CR(8Stx2dact), or, as a control to evaluate Stx-dependent disease,
CR(8Stx2dact::kan
R). (For simplicity of the protocol, and in
contrast to the dose-response studies described above, mice were
not housed on wire floors after inoculation, raising the possibility
that the dose may be somewhat higher due to coprophagy.) In
our first experiment, all five mice infected with CR(8Stx2dact)
crossed a threshold of 4.5% body weight loss on day 5 post
infection, whereas mice infected with CR(8Stx2dact::kan
R) did
not suffer weight loss (Figure 4A; Table 1, Experiment 1). In
addition and in contrast to mice infected with the Stx-deficient
strain, which uniformly survived infection, all mice infected
with CR(8Stx2dact) required euthanasia on day 6 (Figure 4;
Table 1). To assess the reproducibility of the course of disease
in this model, we repeated the experiment three times for a
total of four independent experiments encompassing 20 mice
(Table 1). Although the kinetics of weight loss and required
euthanasia for Experiments 2 through 4 were not as uniform as
in Experiment 1, cumulatively 70% of mice reached the threshold
of >4.5% body weight loss on day 5 post-infection, and all mice
required euthanasia on day 6 or 7 (Table 1). We conclude that
this infection protocol, in contrast to the gavage model using
stationary phase CR(8Stx2dact), results in a highly synchronous
course of disease.
DISCUSSION
Serious life-threatening cases of EHEC infection evolve through
successive phases of illness, beginning asymptomatically but
followed by the development of non-bloody diarrhea, bloody
diarrhea, and, in the most serious cases, culminating in HUS
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FIGURE 2 | Inoculation of mice by feeding CR(8Stx2dact) results in
efficient colonization. Six-week old female C57/BL6 mice were inoculated
with 1 × 108 CR(8Stx2dact) or CR(8Stx2dact::kan
R) by feeding and viable
counts of feces (A), colonic homogenates (B), or luminal washings (C) were
determined by plating. Each point represents an individual mouse and each
line represents the geometric mean.
FIGURE 3 | Food-borne inoculation of mice with as few as 3 × 104
CR(8Stx2dact) results in colonization, disease and mortality. Groups of
five mice were food-inoculated with the indicated dose of CR(8Stx2dact) and
fecal shedding (A), body weight as percent change from that prior to infection
(B) and percent survival (C) were determined as described in Materials and
Methods. In (A), each point represents an individual mouse and each line
represents the geometric mean. For all panels, shown is a representative of
two independent experiments.
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FIGURE 4 | Inoculation with CR(8Stx2dact) by feeding results in
synchronous disease and mortality. Groups of five mice were inoculated
with 1 × 108 CR(8Stx2dact) or CR(8Stx2dact::kan
R), and mean (± SD) body
weight as percent change from that prior to infection (A) and percent survival
were monitored daily (B). ****Indicates p > 0.0001 by 2-way Anova followed
by Bonferroni post-test. Shown is a representative of the four independent
experiments that are described in Table 1.
(Thorpe et al., 2001; Keepers et al., 2006; Obrig, 2010; Mohawk
and O’Brien, 2011; Melton-Celsa et al., 2012; Davis et al.,
2014; Freedman et al., 2016). As the success of a given clinical
intervention may depend on the phase of illness, animal models
of EHEC infection that permit analysis of specific phases
of disease are invaluable to understanding the evolution of
disease and developing successful therapeutic strategies. Murine
infection by oral gavage with CR(8Stx2dact) represents a useful
EHEC infection model that features AE lesion formation,
intestinal epithelial damage, and Stx-mediated renal damage
(Davis et al., 2014). However, this model lacks the synchronicity
of disease evolution, reflected by considerable variation in time
to morbidity (Mallick et al., 2012), thus greatly complicating
detailed investigation of stage-specific pathology.
In the current study, we altered two features of the
existing CR(8Stx2dact) model. First, because C. rodentium
TABLE 1 | Synchronous kinetics of disease following CR(8Stx2dact)
infection.
Initial observance Euthanasia
of >4.5% weight loss requireda
Day 3 Day 4 Day 5 Day 6 Day 6 Day 7
Experiment 1b – – 5/5 – 5/5 –
Experiment 2 – 1/5 4/5 – 5/5 –
Experiment 3 – – 4/4c – 1/5 4/5
Experiment 4 3/5 1/5 – 1/5 – 5/5
Total 3 (15%) 2 (10%) 14 (70%) 1 (5%) 11 (55%) 9 (45%)
aSee Materials and Methods for criteria for euthanasia.
bDepicted in Figure 4 and included here for ease of comparison with Experiments 2–4.
cData for weight loss of one mouse was lost.
anaerobiosis is associated with enhanced acid-resistance and a
transcriptomic profile more similar that of host-adapted, hyper-
infectious bacteria (Smith and Bhagwat, 2013), we changed
our culturing procedures by growing inocula without shaking.
Studies with other enteric pathogens have revealed that the
method of inoculum preparation can have dramatic effects on
virulence in animal models (Clark et al., 1998; Brady et al.,
2011). Second, we infected mice by feeding to avoid potential
physical trauma. In addition, gavage is associated with host
stress, reflected in an increase in heart rate, mean arterial
pressure, and fecal corticosteroids (Hoggatt et al., 2010; Walker
et al., 2012), factors that might contribute to mouse-to-mouse
variability. Mice infected using this modified protocol were
efficiently colonized even at doses as low as 3 × 104 bacteria,
as reflected by titers of CR(8Stx2dact) in feces and colonic
homogenates. (In fact, further infection studies suggest that
food-borne inoculation of doses fewer than 104 CR(8Stx2dact),
2.35 × 103 and 6 × 103, also promotes colonization and
disease; LJF, unpublished data). Although we did not perform
a parallel dose-response study with gavage-delivered bacteria,
this 3 × 104 dose is three or four orders of magnitude lower
than what has been typically used in gavage studies (Vallance
et al., 2003; Tennant et al., 2008; Bergstrom et al., 2010; Diez
et al., 2011; Kamada et al., 2012). In contrast to this study,
a previous study with gavage-inoculated mice suggested that
fecal shedding of CR(8Stx2dact) was slightly higher than that
of CR(8Stx2dact::kan
R) (Mallick et al., 2012, 2014). However,
detection of a statistically significant difference in colonization
required much larger numbers of mice (n ≥ 20) than utilized in
this study.
Importantly, compared with the previously described
gavage model, infection using our model produced
relatively synchronous disease; when four independent
experiments were analyzed together, 70% of mice reached
a threshold of >4.5% body weight loss on day 5 post-
infection, and all mice required euthanasia on day 6 or 7
post-infection. Given that oral gavage is by far the most
common method of inoculation for models of intestinal
pathogens, we speculate that the preparation and inoculation
methods described here might be widely applied to
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improve the reliability and synchronicity of other infection
models.
It is important to note that several aspects of human HUS
are not faithfully replicated in mice. Although murine Stx-
injection or EHEC infection models have been associated with
increased renal (as well as systemic) cytokines, renal damage is
typically limited to tubule pathology and lacks the characteristic
glomerular damage associated with HUS (Mallick et al., 2012;
Melton-Celsa et al., 2012). This difference has been postulated
to be due to the paucity of Gb3, the Stx receptor, on murine
podocytes and renal endothelial cells, whose counterparts in
humans are important targets of Stx intoxication (Keepers et al.,
2006). Genetic manipulation of mice to ectopically produce
Gb3 on critical target cells, in combination with the improved
CR(8Stx2dact) infection protocol described here, might facilitate
the systematic investigation of the evolution of Stx-mediated
disease upon EHEC infection.
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